Effectiveness of Shenshu Guanxin recipe granules ((sic)) for improving exercise tolerance in patients with stable angina pectoris: a randomized, double-blind, placebo-controlled trial

被引:0
作者
Jin, Xiao [1 ]
Wu, Bingxin [2 ]
Wu, Huanlin [3 ]
Xu, Danping [4 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Dept Tradit Chinese Med, Guangzhou 510630, Peoples R China
[2] Guangzhou Univ Chinese Med, Clin Coll 2, Dept Cardiol, Guangzhou 510000, Peoples R China
[3] Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China
[4] Sun Yat sen Univ, Affiliated Hosp 8, Dept Tradit Chinese Med, Shenzhen 518033, Peoples R China
关键词
exercise tolerance; angina; stable; Seattle Angina Questionnaire; Shenshu Guanxin recipe granules; CORONARY-HEART-DISEASE; TRADITIONAL CHINESE MEDICINE; GUIDELINES; INTERVENTION; MANAGEMENT; MECHANISM; PROTOCOL; THERAPY; HEALTH;
D O I
10.19852/j.cnki.jtcm.20231008.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To assess the effectivess of Shenshu Guanxin recipe granules ((sic), SGR) in improving exercise tolerance and the quality of life in patients with Stable Angina Pectoris (SAP). METHODS: A total of 189 patients were consecutively enrolled between December 2012 and December 2014. The included patients were randomly assigned to SGR and placebo groups. The primary endpoints included mainly the results of treadmill exercise test and Seattle Angina Questionnaire (SAQ) during 12 weeks of treatment. RESULTS: After 12 weeks of treatment, SGR extended the time of exercise-induced ST-segment depression of 0.1 MV, lowered the maximum ST-segment depression, and shortened the duration of ST-segment depression in patients with SAP in southern China. Besides, the study also proved that SGR could improve the quality of life and functional status of patients with SAP. CONCLUSIONS: SGR showed a positive effect on exercise tolerance compared with the placebo besides optimal medical therapy. Also, the study proved that SGR could improve the SAQ score of the patients. (c) 2023 JTCM. All rights reserved.
引用
收藏
页码:1227 / 1233
页数:7
相关论文
共 29 条
[1]   Effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris Protocol for a systematic review [J].
Chen, Mingtai ;
Li, Meihuan ;
Ou, Lijun ;
Kuang, Rongren ;
Chen, Yingnan ;
Li, Tao ;
Men, Ling ;
Zhang, Jian ;
Zhang, Zhong .
MEDICINE, 2018, 97 (34)
[2]   Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis [J].
Huang, Jianchun ;
Tang, Xiaojun ;
Ye, Fangxing ;
He, Junhui ;
Kong, Xiaolong .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (05) :1955-1963
[3]   Prevention of platelet aggregation and arterial thrombosis using a modified Shenzhu Guanxin Formula [J].
Huang, Manting ;
Wu, Huanlin ;
Wu, Jianping ;
Chen, Qiuxiong ;
Zou, Dezhi ;
Xu, Danping .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
[4]   Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhoea: protocol for a systematic review of randomised controlled trials [J].
Jo, Junyoung ;
Leem, Jungtae ;
Lee, Jin Moo ;
Park, Kyoung Sun .
BMJ OPEN, 2017, 7 (06)
[5]   Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification [J].
Kaul, Padma ;
Naylor, C David ;
Armstrong, Paul W ;
Mark, Daniel B ;
Theroux, Pierre ;
Dagenais, Gilles R .
CANADIAN JOURNAL OF CARDIOLOGY, 2009, 25 (07) :E225-E231
[6]   Fibrinogen, angina and coronary heart disease in a Chinese population [J].
Lam, TH ;
Liu, LJ ;
Janus, ED ;
Lau, CP ;
Hedley, AJ .
ATHEROSCLEROSIS, 2000, 149 (02) :443-449
[7]   2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery [J].
Levine, Glenn N. ;
Bates, Eric R. ;
Bittl, John A. ;
Brindis, Ralph G. ;
Fihn, Stephan D. ;
Fleisher, Lee A. ;
Granger, Christopher B. ;
Lange, Richard A. ;
Mack, Michael J. ;
Mauri, Laura ;
Mehran, Roxana ;
Mukherjee, Debabrata ;
Newby, L. Kristin ;
O'Gara, Patrick T. ;
Sabatine, Marc S. ;
Smith, Peter K. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2016, 134 (10) :E123-E155
[8]   A review of the mechanism of action of Dantonic® for the treatment of chronic stable angina [J].
Liao, Wenjing ;
Ma, Xiaohui ;
Li, Ju ;
Li, Xinxin ;
Guo, Zhixin ;
Zhou, Shuiping ;
Sun, He .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 :690-700
[9]   Traditional Chinese Medicine Injection for Angina Pectoris: An Overview of Systematic Reviews [J].
Luo, Jing ;
Shang, Qinghua ;
Han, Mei ;
Chen, Keji ;
Xu, Hao .
AMERICAN JOURNAL OF CHINESE MEDICINE, 2014, 42 (01) :37-59
[10]   Impact of stable angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey [J].
Manolis, Athanasios J. ;
Ambrosio, Giuseppe ;
Collins, Peter ;
Dechend, Ralf ;
Lopez-Sendon, Jose ;
Pegoraro, Valeria ;
Camm, A. John .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 70 :60-67